Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹3,074 Cr
down ₹32.7 Cr vs Aug 2025
- Stocks held
- 29
- unchanged
- Top 10 weight
- 62.4%
- of the portfolio in its ten largest
- Cash & debt
- 2.0%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 18
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In September 2025 it disclosed 29 stocks worth ₹3,074 Cr, down ₹32.7 Cr from Aug 2025. Its largest positions were Cipla Limited (8.8%), Sun Pharmaceutical Industries Limited (8.0%), Suven Pharmaceuticals Limited (7.9%); the ten largest together made up 62.4% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 67.7% of its equity. Cash and debt stood at 2.0%. Compared with Aug 2025 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
88%
Top-10 weight is higher than 88% of peers
Breadth
12%
Holds more stocks than 12% of peers
Cash
31%
Holds more cash than 31% of peers
Holdings in September 2025
Download CSVEvery line the fund disclosed, with the change against Aug 2025. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 8.76%
- Δ weight
- down 0.40 pts
- Value
- ₹269 Cr
- Δ value
- down ₹15.4 Cr
- Status
- Trimmed
- Weight
- 7.96%
- Δ weight
- up 0.08 pts
- Value
- ₹245 Cr
- Δ value
- down ₹3 L
- Status
- Held
- Weight
- 7.90%
- Δ weight
- up 0.53 pts
- Value
- ₹243 Cr
- Δ value
- up ₹13.8 Cr
- Status
- Added
- Weight
- 7.39%
- Δ weight
- down 0.17 pts
- Value
- ₹227 Cr
- Δ value
- down ₹7.7 Cr
- Status
- Trimmed
- Weight
- 6.07%
- Δ weight
- down 0.04 pts
- Value
- ₹187 Cr
- Δ value
- down ₹3.3 Cr
- Status
- Trimmed
- Weight
- 5.96%
- Δ weight
- up 0.42 pts
- Value
- ₹183 Cr
- Δ value
- up ₹11.1 Cr
- Status
- Added
- Weight
- 4.77%
- Δ weight
- up 0.25 pts
- Value
- ₹147 Cr
- Δ value
- up ₹6.1 Cr
- Status
- Added
- Weight
- 4.69%
- Δ weight
- down 0.08 pts
- Value
- ₹144 Cr
- Δ value
- down ₹3.9 Cr
- Status
- Trimmed
- Weight
- 4.45%
- Δ weight
- down 0.21 pts
- Value
- ₹137 Cr
- Δ value
- down ₹8 Cr
- Status
- Trimmed
- Weight
- 4.40%
- Δ weight
- down 0.13 pts
- Value
- ₹135 Cr
- Δ value
- down ₹5.6 Cr
- Status
- Trimmed
- Weight
- 4.19%
- Δ weight
- down 0.12 pts
- Value
- ₹129 Cr
- Δ value
- down ₹5.1 Cr
- Status
- Trimmed
- Weight
- 3.29%
- Δ weight
- down 0.08 pts
- Value
- ₹101 Cr
- Δ value
- down ₹3.5 Cr
- Status
- Trimmed
- Weight
- 3.29%
- Δ weight
- down 0.04 pts
- Value
- ₹101 Cr
- Δ value
- down ₹2.4 Cr
- Status
- Trimmed
- Weight
- 3.27%
- Δ weight
- up <0.01 pts
- Value
- ₹100 Cr
- Δ value
- down ₹100 L
- Status
- Trimmed
- Weight
- 3.07%
- Δ weight
- up 0.30 pts
- Value
- ₹94.4 Cr
- Δ value
- up ₹8.2 Cr
- Status
- Added
- Weight
- 3.04%
- Δ weight
- up 0.01 pts
- Value
- ₹93.6 Cr
- Δ value
- down ₹73 L
- Status
- Trimmed
- Weight
- 2.63%
- Δ weight
- down 0.03 pts
- Value
- ₹80.7 Cr
- Δ value
- down ₹1.7 Cr
- Status
- Trimmed
- Weight
- 2.42%
- Δ weight
- down 0.09 pts
- Value
- ₹74.5 Cr
- Δ value
- down ₹3.5 Cr
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 2.05%
- Δ weight
- down 0.18 pts
- Value
- ₹62.9 Cr
- Δ value
- down ₹6.3 Cr
- Status
- Trimmed
- Weight
- 1.64%
- Δ weight
- down 0.13 pts
- Value
- ₹50.3 Cr
- Δ value
- down ₹4.5 Cr
- Status
- Trimmed
- Weight
- 1.48%
- Δ weight
- up 0.05 pts
- Value
- ₹45.6 Cr
- Δ value
- up ₹1.2 Cr
- Status
- Added
- Weight
- 1.35%
- Δ weight
- up 0.06 pts
- Value
- ₹41.5 Cr
- Δ value
- up ₹1.4 Cr
- Status
- Added
- Weight
- 1.28%
- Δ weight
- down 0.10 pts
- Value
- ₹39.3 Cr
- Δ value
- down ₹3.6 Cr
- Status
- Trimmed
- Weight
- 1.22%
- Δ weight
- up 0.04 pts
- Value
- ₹37.6 Cr
- Δ value
- up ₹75 L
- Status
- Added
- Weight
- 0.69%
- Δ weight
- down 0.05 pts
- Value
- ₹21.3 Cr
- Δ value
- down ₹1.9 Cr
- Status
- Trimmed
- Global X Funds - Global X Genomics & Biotechnology ETFFund units
- Weight
- 0.69%
- Δ weight
- up 0.69 pts
- Value
- ₹21.1 Cr
- Δ value
- up ₹21.1 Cr
- Status
- New
- Weight
- 0.66%
- Δ weight
- up 0.02 pts
- Value
- ₹20.3 Cr
- Δ value
- up ₹45 L
- Status
- Added
- Weight
- 0.47%
- Δ weight
- down 0.05 pts
- Value
- ₹14.5 Cr
- Δ value
- down ₹1.6 Cr
- Status
- Trimmed
- Weight
- 0.47%
- Δ weight
- up 0.04 pts
- Value
- ₹14.3 Cr
- Δ value
- up ₹1 Cr
- Status
- Added
- Weight
- 0.30%
- Δ weight
- down 0.01 pts
- Value
- ₹9.1 Cr
- Δ value
- down ₹45 L
- Status
- Trimmed
- Weight
- 0.15%
- Δ weight
- up 0.07 pts
- Value
- ₹4.6 Cr
- Δ value
- up ₹2.1 Cr
- Status
- Added
What changed, Aug 2025 to Sep 2025
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Suven Pharmaceuticals Limitedup ₹13.8 Cr (+0.53% pts)
- Gland Pharma Limitedup ₹11.1 Cr (+0.42% pts)
- Indoco Remedies Limitedup ₹8.2 Cr (+0.30% pts)
- Sai Life Sciences Limitedup ₹6.1 Cr (+0.25% pts)
- Grail Incup ₹2.1 Cr (+0.07% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Aug 2025, the weight rose most in Pharmaceuticals & Biotechnology (+0.4 pts) and Pharmaceuticals (+0.2 pts), and fell most in Healthcare Equipment & Supplies (−0.3 pts) and Healthcare Services (−0.3 pts).
- Pharmaceuticals & Biotechnology67.3% → 67.7%+0.4 pts
- Pharmaceuticals5.5% → 5.7%+0.2 pts
- Healthcare Equipment & Supplies7.7% → 7.4%−0.3 pts
- Healthcare Services17.5% → 17.2%−0.3 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Sep 2022 | Sep 2024 | Mar 2025 | Jun 2025 | Aug 2025 | Sep 2025 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 59.2% | 66.7% | 66.4% | 67.0% | 67.3% | 67.7% |
| Healthcare Services | 25.1% | 17.7% | 17.2% | 16.7% | 17.5% | 17.2% |
| Healthcare Equipment & Supplies | 5.6% | 8.0% | 8.7% | 7.8% | 7.7% | 7.4% |
| Pharmaceuticals | 6.7% | 5.4% | 5.7% | 6.3% | 5.5% | 5.7% |
| Insurance | 2.4% | 1.8% | 1.5% | 1.6% | 1.5% | 1.5% |
| Retailing | 1.0% | 0.4% | 0.5% | 0.6% | 0.5% | 0.5% |
Allocation in Sep 2025change vs Aug 2025
- Pharmaceuticals & Biotechnology (14)67.7%▲ 0.4 pts
- Healthcare Services (7)17.2%▼ 0.3 pts
- Healthcare Equipment & Supplies (3)7.4%▼ 0.3 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Sep 2025
2.0%
▼ 0.2 pts vs Aug 2025
- Cash alone
- 2.0%
- cash and net receivables
- A year earlier
- 3.3%
- Sep 2024 · now ▼ 1.2 pts
- Last 12 months
- 0.1% – 4.8%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.